Trends in hospital admission for stroke in Calgary

Canadian Journal of Neurological Sciences

Volumn 31, Issue 3, 2004, Pages 387-393

  Field, T S ^a   Green, T L ^b   Roy, K ^b   Pedersen, J ^b   Hill, M D ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CALGARY HEALTH REGION   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; DEEP VEIN THROMBOSIS; DISEASE COURSE; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LINEAR REGRESSION ANALYSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 4644236217     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100003504     Document Type: Article

References (49)

1. Broderick JP. Stroke trends in Rochester, Minnesota, during 1945 to 1984. Ann Epidemiol 1993;3:476-479.
2. McGovern PG, Burke GL, Sprafka JM, et al. Trends in mortality, morbidity and risk factor levels for stroke from 1960 through 1990: The Minnesota Heart Survey. JAMA 1992;268:752-759.
3. Lemesle M, Milan C, Faivre J, et al. Incidence trends of ischemic stroke and transient ischemic attacks in a well-defined French population from 1985 through 1994. Stroke 1999;30:371-377.
4. Truelsen T, Prescott E, Gronbaek M, Schnohr P, Boysen G. Trends in stroke incidence: the Copenhagen city heart study. Stroke 1997;28:1903-1907.
5. Brown RD, Whisnant JP, Sick JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-380.
6. Pessah-Rasmussen H, Engström G, Jerntorp I, Janzon L. Increasing stroke incidence and decreasing case fatality, 1989-1998. Stroke 2003;34:913-918.
7. Thorvaldsen P, Davidsen M, Brønnum-Hansen H, Schroll M. Stable stroke occurrence despite incidence reduction in an aging population: stroke trends in the Danish monitoring trends and determinants in cardiovascular disease (MONICA) population. Stroke 1999;30:2529-2534.
8. Heart and Stroke Foundation of Canada. Heart Disease and Stroke in Canada. Ottawa: Heart and Stroke Foundation of Canada; 1997.
9. Bata IR, Eastwood BJ, Gregor RD, et al. Decreasing mortality from acute myocardial infarctions: effect of attack rates and case severity. J Clin Epidemiol 1997;50:787-791.
10. Davies JW, Semenciw RM, Mao Y. Cardiovascular disease mortality trends and related risk factors in Canada. Can J Cardiol 1988;4 (Suppl A):16A-20A.
11. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988;38:155-168.
12. Bonneux L, Looman CWN, Barendregt JJ, Van der Maas PJ. Regression analysis of recent changes in cardiovascular mobility and mortality in the Netherlands. Br Med J 1997;314:789-792.
13. Abildstrom SZ, Rasmussen S, Rosen M, Madsen M. Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden. Heart 2003;89:507-511.
14. Messner T, Lundberg V. Trends in sudden cardiac death in the northern Sweden MONICA area 1985-99. J Intern Med 2003;253:320-328.
15. Sudlow CLM, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997;28:491-499.
16. Korv J, Roose M, Kaasik AE. Changed incidence and case-fatality rates of first-ever stroke between 1970 and 1993 in Tartu, Estonia. Stroke 1996;27:199-203.
17. Sarti C, Stegmayr B, Tolonen H, et al, for the WHO MONICA Project. Changes in mortality from stroke caused by changes in stroke event rates of case fatality? Stroke 2003;34:1833-1841.
18. Broderick JP. Stroke trends in Rochester, Minnesota, during 1945 to 1984. Ann Epidemiol 1993;3:476-479.
19. McGovern PG, Burke GL, Sprafka JM, et al. Trends in mortality, morbidity and risk factor levels for stroke from 1960 through 1990: The Minnesota Heart Survey. JAMA 1992;752-759.
20. Field TS, Hill MD. Stroke, chinook and the weather. Stroke 2002;33:1751-1778.
21. Yiannakoulias N, Svenson LW, Hill MD, et al. Regional comparison of inpatient and outpatient patterns of cerebrovascular disease diagnosis in the province of Alberta. Chronic Dis Can 2003;24:9-16.
22. Canadian Stroke Network. Facts Sheet. 2003. Available from: URL: http://www.canadianstrokenetwork.ca/media/downloads/fact.she et.e.pdf
23. Mayo NE, Neville D, Kirkland S, et al. Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke 1996;27:1215-1220.
24. Ostbye T, Levy AR, Mayo NE. Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke 1997;28:793-798.
25. Broderick JP, Viscoli CM, Brott T, et al. Major risk factors for aneurismal subarachnoid hemorrhage in the young are modifiable. Stroke 2003;34:1375-1381.
26. Statistics Canada. "Smoking." The Canada e-Book. Ottawa: Statistics Canada; 2001. Available from: URL: http://142.206.72.67/02/02b/ 02b_007a_e.htm. Accessed August 2003.
27. Willinsky RA. Detachable coils to treat intracranial aneurysms. Can Med Assoc J 1999;161:1136.
28. Lozier AP, Connolly ES Jr, Lavine SD, Solomon RA. Guglielmi detachable coil embolization of posterior circulation aneurysms: a systematic review of the literature. Stroke 2002;33:2509-2518.
29. Vallee JN, Aymard A, Vicaut E, Reis M, Merland JJ. Endovascular treatment of basilar tip aneurysms with Guglielmi detachable coils: Predictors of immediate and long-term results with multivariate analysis 6-year experience. Radiology 2003;226:867-879.
30. Willinsky RA. Detachable coils to treat intracranial aneurysms. Can Med Assoc J 1999;161:1136.
31. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267-1274.
32. Mayo NE, Goldberg MS, Levy AR, Danys I, Korner-Bitensky N. Changing rates of stroke in the province of Quebec, Canada: 1981-1988. Stroke 1991;22:590-595.
33. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. New Eng J Med 1995;333:1581-1587.
34. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke. The Cochrane Library 1999; Issue 4.
35. Stroke Unit Trialists' Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomised trails of organised inpatient (stroke unit) care after stroke. Br Med J 1997;314:1151-1159.
36. Samsa GP, Matchar DB, Goldstein L, et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J 1998;136:703-713.
37. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke 1994;25:1721-1725.
38. Hillbom M, Erila T, Sotaniemi K, et al. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand 2002;106:84-92.
39. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke 2001;32:262-267.
40. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Q J Med 2000;93:359-364.
41. Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc 1997;72:297-300.
42. Dumas R, Woitinas F, Kutnowski M, et al. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age Ageing 1994;23:512-516.
43. Hill MD, Barber PA, Demchuk AM, et al. Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke. Can Med Assoc J 2000;162:1589-1593.
44. Proctor MC, Greenfield LJ. Pulmonary embolism: diagnosis, incidence and implications. Cardiovasc Surg 1997;5:77-81.
45. Espino JU, Wagner MM. Accuracy of ICD-9-coded chief complaints and diagnoses for the detection of acute respiratory illness. Proc AMIA Symp 2001;164-168.
46. Marrie TJ, Durant H, Sealy E. Pneumonia-the quality of medical records data. Med Care 1987;25:20-24.
47. Campbell NR, McAlister FA, Brant R, et al for the Canadian Hypertension Education Process and Evaluation Committee. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens 2003;21:1591-1597.
48. Hamilton VH, Levinton C, St-Pierre Y, Grimard F. The effect of tobacco tax cuts on cigarette smoking in Canada. Can Med Assoc J 1997;156:187-191.
49. Levy AR, O'Brien BJ, McMullen E, et al. Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000. Can J Cardiol 2003;9:665-669.